Histidine-Rich Glycoprotein (HRG) in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia

W M Halbmayer; P Hopmeier; C Feichtinger; K Rubi; M Fischer

doi:10.1055/s-0038-1648499

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1992; 67(05): 585-586
DOI: 10.1055/s-0038-1648499

Letters to the Editor

Schattauer GmbH Stuttgart

Histidine-Rich Glycoprotein (HRG) in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia

W M Halbmayer

Central Laboratory, Municipal Hospital of the City of Vienna-Lainz, A-1130 Vienna, Austria

,

P Hopmeier

^*Central Laboratory, Municipal Hospital Rudolfstiftung, Vienna

,

C Feichtinger

Central Laboratory, Municipal Hospital of the City of Vienna-Lainz, A-1130 Vienna, Austria

,

K Rubi

^**Central Laboratory, Kaiserin-Elisabeth Hospital, Vienna

,

M Fischer

Central Laboratory, Municipal Hospital of the City of Vienna-Lainz, A-1130 Vienna, Austria

› Institutsangaben

Abstract

als PDF herunterladen

PDF (319 kb)

Referenzen

References
1 Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemostas 1984; 52: 176-182
2 Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981; 12: 141-154
3 Kruithof EKO, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C, Welti H, Bachmann F. Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors. Blood 1987; 69: 460-466
4 Walker JE, Campbell DM, Ogston D. Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol 1982; 89: 208-210
5 Morgan WT, Koskelo P, Koenig H, Conway TP. Human histidine-rich glycoprotein. II. Serum levels in adults, pregnant women and neonates. Proc Soc Exp Biol Med 1978; 158: 647-651
6 Haukkamaa M, Morgan WT, Koskelo P. Serum histidine-rich glycoprotein during pregnancy and hormone treatment. Scand J Clin Lab Invest 1983; 43: 591-595
7 Heimburger N, Haupt H, Kranz T, Baudner S. Humanserumproteine mit hoher Affinitat zu Carboxymethylzellulose, II. Physikalisch-chemische und immunologische Charakterisierung eines histidin-reichen 3,8S-alpha₂-Glykoproteins (CM-Protein I). Hoppe-Seyler’s Z Physiol Chem 1972; 353: 1133-1140
8 Lijnen HR, Hoylaerts M, Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem 1980; 255: 10214-10222
9 Peterson CB, Morgan WT, Blackburn MN. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. J Biol Chem 1987; 262: 7567-7574
10 Leung LLK. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest 1986; 77: 1305-1311
11 Leung LLK, Nachman RL, Harpel PC. Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest 1984; 73: 5-12
12 Heimburger N. Personal communication 1990
13 Halbmayer WM, Hopmeier P, Mannhalter C, Heuss F, Leodolter S, Rubi K, Fischer M. Cl-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia. Thromb Haemostas 1991; 65: 134-138
14 Goecke C, Schwabe G. Vorschlag einer Stadieneinteilung der Ge-stose. Zentralbl Gynaekol 1965; 42: 1439
15 Kemeter P, Friedrich F. Die Endokrinologie der Schwangerschaft. In: Klinik der Frauenheilkunde und Geburtshilfe. Vol.I. Doderlein G, Wulf KH. (eds) Urban and Schwarzenberg; Munich: 1977. Addendum 1978. pp 219-60/31
16 Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979; 6: 65-70
17 Jespersen J, Kluft C. Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen. Thromb Haemostas 1982; 48: 283-285
18 Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Jones PK. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased Cl esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980; 96: 762-769
19 Jespersen J, Kluft C. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen - levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and Cl-inactivator. Thromb Haemostas 1985; 54: 454-459
20 Lijnen HR, Jacobs G, Collen D. Histidine-rich glycoprotein in a normal and a clinical population. Thromb Res 1981; 22: 519-523
21 Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Jones PK. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased Cl esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980; 96: 762-769
22 Halbmayer WM. Unpublished data 1991
23 Lappin D, Whaley K. Regulation of Cl-inhibitor synthesis by interferons and other agents. Behring Inst Mitt 1989; 84: 180-192